Would you avoid the use of a TNF inhibitors in patients with a remote history of melanoma, including those with ocular melanoma?

Clinical trials of TNF inhibitors have identified a small but increased risk of malignancy with the use of TNF inhibitors, and most, but not all, of the follow-up studies done with real-world registries have confirmed this. These registries are of course sometimes affected by the behavior of physici...